Effects of defibrotide in patients with chronic deep insufficiency. The PROVEDIS study

International Angiology

Volumn 23, Issue 2, 2004, Pages 100-107

  Coccheri, S ^a   Andreozzi, G M ^b   D'addato, M ^a   Gensini, G F ^c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Fibrinolytic agents; Venous insufficiency, therapy; Venous thrombosis

Indexed keywords

DEFIBROTIDE; DIOSMIN; DOBESILATE CALCIUM; ESCIN; HESPERIDIN; MONOXERUTIN; PLACEBO; RUSCUS ACULEATUS EXTRACT;

ABDOMINAL PAIN; ADULT; ANKLE; ARTICLE; CHRONIC VEIN INSUFFICIENCY; CLINICAL TRIAL; COMPRESSION THERAPY; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ECHOGRAPHY; FEMALE; HEADACHE; HEARTBURN; HEMATOMA; HUMAN; LEG EDEMA; LEG PAIN; MALE; MULTICENTER STUDY; POSTTHROMBOSIS SYNDROME; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STOMACH PAIN; THROMBOPHLEBITIS; THROMBOSIS; VEIN OCCLUSION;

AGED; ANKLE; BANDAGES; CHRONIC DISEASE; DOUBLE-BLIND METHOD; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; POLYDEOXYRIBONUCLEOTIDES; ULTRASONOGRAPHY, DOPPLER; VASCULAR DISEASES; VENOUS THROMBOSIS;

EID: 7044235274     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Fowkes FG, Evans CG, Lee AJ. Prevalence and risk factors of chronic venous insufficiency Angiology 2001;52 Suppl 1:S5-15.
2. Van den Oever R, Hepp B, Debbaud B, Simon I. Socio-economic impact of chronic venous insufficiency. An underestimated public health problem. Int Angiol 1998;17:161-7.
3. Evans CJ, Fowkes FG, Ruckley CV, Lee AJ. Prevalence of varicose veins and chronic venous insufficiency in men and women in the general population: Edinburgh Vein Study. J Epidemiol Community Health 1999;53:149-53.
4. Guidelines for diagnosis and therapy of diseases of the vein and lymphatic vessels. Evidence based report by the Italian College of Phlebology. Int Angiol 2001;20 (2 Suppl 2):1-32.
5. Linee Guida Diagnostico-Terapeutiche delle malattie delle vene e dei linfatici. Collegio Italiano di Flebologia. Acta Phlebologica 2003;4:1-52.
6. Nicolaides AN. Investigation of chronic venous insufficiency. A Consensus Statement. Circulation 2000;102: 126-63
7. Prandoni P, Lensing AWA, Cogo A, Cuppini S, Villalta S, Carta M et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996;125:1-7.
8. Spence RK, Cahal E. Inelastic versus elastic leg compression in chronic venous insufficiency: a comparison of limb size and venous hemodynamics. J Vasc Surg 1996;24: 783-7.
9. Palmer KJ, Goa KL. Defibrotide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in vascular disorders. Drugs 1993;45:259-94.
10. Coccheri S, Biagi G. Defibrotide. Cardiovasc Drug Rev 1991;9:172-96.
11. Violi F, Ferro D, Saliola M, Quintarelli C, Basili S, Balsano F. Effect of oral defibrotide on tissue-plasminogen activator inhibitor balance. Eur J Clin Pharmacol 1992;42: 379-83.
12. Richardson PG, Elias AD, Krishnan A, Wheeler C, Nath R, Hoppensteadt D et al. Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population. Blood 1998;92:737-44.
13. Violi F, Marubini E, Coccheri S, Nenci GG. Improvement of walking distance by defibrotide in patients with intermittent claudication: results of a randomized, placebo-controlled study (the DICLIS study). Defibrotide Intermittent CLaudication Italian Study. Thromb Haemost 2000;83:672-7.
14. Biagi G, Legnani C, Rodorigo G, Coccheri S. Modulation of arachidonate metabolite generation in human blood by oral defibrotide. Arzneimittelforschung 1991;41:511-5.
15. Cloarec M. A double blind clinical trial of hydroxyethylrutosidea in the treatment of symptoms and signs of chronic venous insufficiency. Phlebology 1996;11:76-82.
16. Kiesewetter H, Koscielny J, Kalus U, Vix JM, Peil H, Petrini O et al. Efficacy of orally administered extract of red vine leaf AS 195 (folia vitis viniferae) in chronic venous insufficiency (stages I-II). A randomized, double-blind, placebo-controlled trial. Arzneimittelforschung 2000;50: 109-17.
17. Fleiss JL. The parallel group design. In: Fleiss JL, editor. The design and analysis of clinical experiments. New York: John Wiley and Sons; 1986.p.46-51.
18. SAS Institute. SAS's user guidelines: basic version. 5th ed. Cary NC: SAS Institute; 1985.
19. Hopkins NFG, Wolfe JHN. Deep venous insufficiency and occlusion. BMJ 1992;304:107-10.
20. Holmstrom M, Aberg W, Lockner D, Paul C. Long term clinical follow up in 265 patients with deep venous thrombosis initially treated with either unfractionated heparin or dalteparin: a retrospective analysis. Thromb Haemost 1999;82:1222-6.
21. Lyseng-Williamson KA, Perry CM. The purified micronized flavonoid fraction. A review of the literature. Drugs 2003;63:71-100.
22. Jantet G. Chronic venous insufficiency: worldwide results of the RELIEF study. Reflux assessment and quality of life improvement with micronized flavonoids. Angiology 2002;53:245-56.
23. Nocker W, Diebschlag W, Lehmacher W. Clinical trials of the dose-related effects of 0-(β-hydroxyethyl)-rutosides in patients with chronic venous insufficiency Phlebology 1990;5 Suppl 1:23-6.
24. Boyle P, Diehm C, Robertson C. Meta-analysis of clinical trials of Cyclo 3 Fort in the treatment of chronic venous insufficiency. Int Angiol 2003;22:250-62.
25. Wildmer L, Biland L, Barras JP. Doxium (500 in chronic venous insufficiency: a double-blind placebo controlled multicentre study. Int Angiol 1990;9:105-10.
26. Pittler MH, Ernst E. Horse-chestnut seed extract for chronic venous insufficiency. (Cochrane Review). In: The Cochrane Library 2003, Issue 4, Oxford: Update Software.
27. Coleridge Smith PD. The drug treatment of chronic venous insufficiency and venous ulceration. In: Gloviczki P, Yao JST, editors. Handbook of Venous Disorders-Guidelines of the American Venous Forum, Chapter 31. London: Arnold; 2001.p.309-21.